Bharat Biotech in tie-up with the US-based company FluGen and University of Wisconsin Madison to develop a vaccine named “Coro-Flu” to fight against COVID-19. CoroFlu will build on the backbone of FluGen’s flu vaccine candidate known as M2SR.
Click Here To Get Test Series For SBI PO 2020
The vaccine is being developed on the basis of FluGen’s flu vaccine candidate known as M2SR, a self-limited version of the influenza virus. It induces an immune response against the flu. The vaccine will be built by FluGen’s lab that inserts gene sequences from SARS-CoV-2, the novel coronavirus that causes the disease COVID-19 into M2SR so that the novel vaccine will also induce immunity against the coronavirus.
Important takeaways for all competitive exams:
The impeachment motion against the Chief Election Commissioner (CEC) Gyanesh Kumar has been rejected by…
Vinay Tonse has officially taken charge as the Managing Director and CEO of YES Bank.…
Divya Singh from the Uttar Pradesh has achieved the remarkable feat as she cycling to…
World Health Day 2026 is observed on 7th April and will brings the strong global…
Air travel has become an important part of our daily life today, but it all…
India has achieved the major milestone in its nuclear energy journey as indigenously developed Prototype…